Sanofi SA: second-week sell signal, strength at the bottom of the ranking
Sanofi SA carries a second-week sell signal, but ranks last among EU-UK sell signals with strength at 2 out of 100. Quality band flags trading not recommended: elevated-risk opening per our model.
Safran SA: weak bearish pressure in a high-risk setup
Safran SA is in the third week of a sell signal with fading strength at 24 out of 100. Our model flags trading as not recommended: current conditions do not justify opening a short position at this stage.
Recursion Pharmaceuticals: fresh sell signal in a high-risk setup
Recursion Pharmaceuticals gets a fresh weekly sell signal in week 1. Signal strength is low at 22 out of 100, and our model flags elevated-risk conditions: trading not recommended.
RTX Corporation: fading strength, adverse confirmation week
Sell signal on RTX Corporation at week 7, with signal strength at 12 out of 100 and fading. Our model flags elevated-risk conditions. The confirmation week closed bullish, suggesting an exit from the position.
Roku at Week 6: first window cleared, signal still solid
Roku Inc is in week 6 of a buy with signal strength 86 out of 100 and the first DL2 target already hit at week 4. Stop is at breakeven: trade risk is zeroed out. The next management window falls at week 8.
Hermès: three sideways weeks leave the sell signal unconfirmed
The sell signal on Hermes International has been active for 16 weeks but failed to confirm over 3 observation weeks. Our model flags elevated-risk conditions, with signal strength at 25 out of 100 and fading.